Plasma Therapy Market Report 2025 (Global Edition)

Global Plasma Therapy Market Report 2025 Market Size Split by By Product Type (Immunoglobulin, Coagulation factors, Albumin, Others), by By Application (Hemophilia, Primary immunodeficiency disease, I...

Plasma Therapy Market Report Description

We have various report editions of Plasma Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

How 2025 Tariffs Are Reshaping the Consumer Goods Industry

In 2025, the global trade landscape has shifted dramatically following the U.S. introduction of sweeping tariffs under President Donald Trump’s administration. These "Liberation Day Tariffs," launched in April, aim to reduce trade deficits and boost domestic manufacturing. Tariffs range from 10% on imports from countries like the UK and Australia to 46% on Vietnamese goods, with a blanket 34% tariff on many Chinese imports and 25% on all steel, aluminum, and auto parts. This policy heavily impacts the consumer goods sector apparel, appliances, packaged foods, and personal care products due to their deep reliance on global supply chains, especially in Asia. U.S.–China trade tensions have intensified, with reciprocal tariffs reaching up to 145% on U.S. goods and 125% on Chinese exports, while China’s trade surplus with the U.S. hit USD 102.6 billion in March 2025. In response, the EU and Canada have implemented retaliatory measures, signaling a broader shift toward protectionism.

The consumer goods industry is feeling immediate effects: production costs are rising, sourcing is delayed, and inflation pressures are mounting. Apparel and footwear now face 25% tariffs, prompting brands to seek nearshoring options or raise prices. Household appliances incur 20% tariffs, complicating inventory and procurement strategies. Packaged foods and beverages are hit with 10–15% tariffs, impacting contracts and leading to supplier diversification and product reformulation. Personal care firms face higher costs for imported ingredients and packaging, leading to local sourcing efforts and delays in new product launches. Meanwhile, electronics, though temporarily exempt, are preparing for possible disruptions by diversifying suppliers and increasing inventories.

China remains the backbone of U.S. consumer goods sourcing, accounting for a large portion of imports either directly or through upstream components. This makes tariffs on Chinese goods especially disruptive. The rising input costs 15–30% in many categories combined with seasonal pressures and tight timelines, are causing delays and increased costs. Smaller brands, in particular, are struggling due to limited capital and reduced supplier leverage. Many are being forced to increase prices, cut product variety, or compromise on quality.

Market research is now critical to navigating this volatile environment. It supports supplier mapping and risk assessment, helping brands identify alternative sourcing countries with stable regulations and quality control. It also aids in cost and margin analysis, guiding decisions on pricing and sourcing changes. Optimization of product design and materials through research allows companies to reduce costs while maintaining consumer expectations. Additionally, research helps assess consumer price sensitivity, enabling strategic repositioning. Tracking regulatory changes and running scenario planning models allow firms to anticipate and adapt to future trade shifts.

To cope, companies are restructuring their global sourcing models. Major brands like Nike and IKEA are expanding operations in Vietnam, India, and Mexico, while embracing “in-market for market” strategies to reduce exposure to tariffs and logistics risks. Many are adopting AI-driven demand forecasting and automated procurement, and pushing suppliers for transparency. Product redesign and SKU rationalization are also common. The most successful firms are those using data-driven insights, operational flexibility, and strategic supplier partnerships to adapt not just survive in this new era of global trade.

In February 2024, entrepreneur Bryan Johnson, who is famous for his anti-aging routines, posted about his use of PRP for hair regrowth. His testimony has contributed to the increasing popularity of PRP in the aesthetics industry.
(Source- https://www.globenewswire.com/)
RegenLab USA in January 2024 increased the size of its headquarters in Jersey City, New Jersey, expanding its manufacturing and research capabilities in order to keep up with increased demand for PRP-based products.
(Source- https://www.globenewswire.com/)

Which Region is Expanding at the Fastest CAGR?

According to Cognitive Research, Asia Pacific is projected to grow at a CAGR of XX% over the period. The purpose of this initiative is to improve water management practices and infrastructure, providing all European citizens with access to safe and clean water. This will create a higher demand for water testing equipment in the local market. The European Union (EU) has put into place an overarching framework of water policy that is regulated through three main directives: the drinking water directive, the water framework directive, and the urban wastewater treatment directive.

Top Companies Market Share in Plasma Therapy Industry: (In no particular order of Rank)

• CSL Behring
• Grifols S.A.
• Kedrion S.p.A.
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Zimmer Biomet
• Baxter International Inc.
• China Biologic Products Holdings
• Inc.
• GC Pharma
• Green Cross Corp.
• Other
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region will dominate the Market in 2024?

The Asia-Pacific market, which incorporates Japan, South Korea, China, and India, has also seen a considerable growth in plasma therapy adoption in the last few years. PRP therapy in both medical and aesthetic use has become commonplace in Japan and South Korea, countries where aesthetic medicine is deeply embedded in the local culture. PRP is a widely used therapy for skin renewal, and as a hair restoration treatment, it has found much popularity in South Korea and other nations where there is a very high standard of beauty.

Which Region is Expanding at the Fastest CAGR?

According to Cognitive Research, Plasma therapy is the most used treatment in North America, especially the United States and Canada, owing to developed healthcare infrastructure, high medical research, and a high level of healthcare expenditure. PRP therapy has also gained extensive application in sports medicine, where it is used to address tendon injuries, osteoarthritis, and ligament injury. Sportspeople, particularly those participating in high-impact sports, have fueled demand for PRP as a non-surgical remedy for recurring injuries.

The current report Scope analyzes Plasma Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Plasma Therapy Market Analysis

Immune replacement in congenital and acquired immunodeficiencies Immunomodulation in other haematological (e.g. immune thrombocytopenic purpura), neurological (e.g. Guillain-Barré syndrome), dermatological and miscellaneous conditions (e.g. Kawasaki syndrome), generally only when other treatments have failed or are contraindicated.
Warfarin reversal and prophylaxis and treatment of bleeding in patients with single or multiple congenital or acquired factor II or X deficiencies or multiple acquired prothrombin complex factor deficiencies requiring partial or complete reversal.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Plasma Therapy Industry. Request a Free Sample PDF!

By Application Segment Analysis of Plasma Therapy Market

This industry is one of the most evolving industry, driven by advanced technologies, changing consumer preferences, urbanization and rising disposable income. In this chapter, we present the Plasma Therapy market size, revenue share, and growth rate for each application/end-user segment, both globally and at the regional level.

Additionally, we provide qualitative insights, such as key driving and restraining factors that influence the growth of the Plasma Therapy market. This section offers valuable information for companies to gain a deeper understanding of market trends, challenges, and technological advancements. By leveraging this analysis, businesses can develop strategies and make well informed decisions to stay competitive in a rapidly changing and highly competitive market.

Some of the key By Application of Plasma Therapy are:

• Hemophilia
• Primary immunodeficiency disease
• Idiopathic thrombocytopenic purpura
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Plasma Therapy By End-User Segment Analysis

• Hospitals and clinics
• Research institutes

Author's Detail

Sneha Mali

Research Analyst at Cognitive Market Research

LinkedIn

Profile

I am a research analyst working in various domains including the Consumer Goods domain, and my primary responsibility is to conduct thorough research on various subjects and provide valuable insights to support client requirements. I have knowledge of research methodologies, and data mining which enables me to analyze large data sets, draw meaningful conclusions, and communicate them effectively. I stay up-to-date with the latest research trends, methodologies, and technologies to ensure that my research is accurate, relevant, and impactful.

Author's Conclusion